1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Design Therapeutics Inc (DSGN)
  7. Quote

DSGN DSGN

Design Therapeutics Stock Price

14.77
-0.24 (-1.6%)
Upgrade to Real-Time
Regular Market
14.77
Volume 1,165
Bid Price 14.75
Ask Price 15.48
News -
Day High 15.27

Low
12.52

52 Week Range

High
50.00

Day Low 14.54
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Design Therapeutics Inc DSGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.24 -1.6% 14.77 10:32:08
Open Price Low Price High Price Close Price Prev Close
14.84 14.54 15.27 15.01
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
51 1,165 $ 14.78 $ 17,222 - 12.52 - 50.00
Last Trade Time Type Quantity Stock Price Currency
10:32:31 1 $ 14.751 USD

Period:

Draw Mode:

Design Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 835.26M 55.11M 26.95M $ 226.00k $ - -0.30 -25.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 40.00k 2.00%

more financials information »

Design Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical DSGN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week14.0715.2913.846214.8249,3910.704.98%
1 Month14.4415.9912.5214.3789,0370.332.29%
3 Months15.8019.0012.5215.5182,061-1.03-6.52%
6 Months20.3029.1612.5220.93114,975-5.53-27.24%
1 Year28.0050.0012.5223.21134,736-13.23-47.25%
3 Years28.0050.0012.5223.21134,736-13.23-47.25%
5 Years28.0050.0012.5223.21134,736-13.23-47.25%

Design Therapeutics Description

Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.


Your Recent History
NASDAQ
DSGN
Design The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.